Legal & Medical Notice

1. 01Not medical advice. The information on this site is educational and scientific in nature and does not replace consultation with a licensed physician, diagnosis, or treatment. Do not use it for self-diagnosis or self-treatment.
2. 02Research status. Longevium Health is a science program. The directions, products, protocols, and technologies described on this site are under active R&D, preclinical, or clinical investigation and are not registered medical products or services unless explicitly stated.
3. 03No guarantee of outcomes. We make no guarantee of any clinical result, life extension, reduction in biological age, or cure of any disease. Individual outcomes vary and depend on many factors.
4. 04Regulatory scope. Availability of specific studies, pilots, and services depends on jurisdiction and applicable regulation. Nothing on this site constitutes a public offer, advertising of medicinal products, or promotion of medical services in jurisdictions where this is restricted.
5. 05Partnerships & data. Engagement with startups, researchers, and clinics is governed by separate agreements. Personal and health data is processed in accordance with applicable law.
6. 06No investment offer. Materials on this site are informational only and do not constitute an offer, recommendation, solicitation, or invitation to buy, sell, or subscribe to any securities, equity interests, or other financial instruments of Longevium Health or its affiliates. This site is not a prospectus and has not been registered with, or reviewed by, any financial regulator.
7. 07Forward-looking statements. Statements about future research, R&D agenda, pilots, products, partnerships, licensing, IP, regulatory speed, and market opportunities are forward-looking and based on current assumptions. Actual outcomes may differ materially due to scientific, clinical, regulatory, market, and operational risks.
8. 08Investor risk. Early-stage science and medtech ventures carry a high risk of total loss of capital, long time-to-return, illiquidity, dilution, and dependence on regulatory approvals, clinical results, IP status, and key personnel. Prospective and existing investors must obtain independent legal, tax, and financial advice.
9. 09Restricted audience. Any discussion of a potential investment is conducted solely with professional, qualified, or accredited investors in jurisdictions where this is permitted, and only on the basis of separate documentation (term sheet, SAFE / SPA, disclosure package). Nothing on this site creates any contractual obligation.
10. 10No guaranteed return. We do not guarantee any profit, dividend, exit, valuation, timing, or return on investment. Past performance and media coverage are not indicators of future performance.
11. 11Trademarks & third parties. References to third parties, media, guidelines (WHO, NICE, ESC, IDSA, ADA), and partners are informational and do not imply their endorsement or sponsorship of Longevium Health.
12. 12Jurisdiction. These materials are intended for a general audience and are not directed at any person in a jurisdiction where their distribution or use is prohibited. Users are responsible for compliance with applicable local law.